Summary Marketline's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage.
This report includes GlobeImmune, Inc.'s contact information and business summary, tables, graphs, a list of partners and targets, a breakdown of financial and legal advisors, deal types, top deals by deal value, detailed deal reports, and descriptions and contact details of the partner, target, investor, and vendor firms, where disclosed.
The profile also includes detailed deal reports for all M&A, private equity, public offering, venture financing, partnership and divestment transactions undertaken by GlobeImmune, Inc.. These deal reports contain information about target company financials, sources of financing, method of payment, deal values, and advisors for various parties, where disclosed.
Key Findings Marketlines' GlobeImmune, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital raisings, venture capital investments, ownership and partnership transactions undertaken by GlobeImmune, Inc. since January 2007.
Synopsis - Provides intelligence on GlobeImmune, Inc.'s M&A, strategic partnerships and alliances, capital raising and private equity transactions.
- Detailed reports of various financial transactions undertaken by GlobeImmune, Inc. and its subsidiaries since 2007.
- Information about key financial and legal advisors for GlobeImmune, Inc.'s financial deals transactions.
- Financial deals tables and charts covering deal value and volumes trend, deal types and geography-based deal activity.
Reasons To Buy - Access comprehensive financial deals data along with charts and graph covering M&A, private equity, and partnerships and alliances.
- Form an independent opinion about GlobeImmune, Inc.’s growth strategies through the organic and inorganic activities undertaken since 2007.
- Track your competitors’ business structure and growth strategies.
Key Highlights This report includes GlobeImmune, Inc.'s contact information and business summary, tables, graphs, a list of partners and targets, a breakdown of financial and legal advisors, deal types, top deals by deal value, detailed deal reports, and descriptions and contact details of the partner, target, investor, and vendor firms, where disclosed.
The profile also includes detailed deal reports for all M&A, private equity, public offering, venture financing, partnership and divestment transactions undertaken by GlobeImmune, Inc.. These deal reports contain information about target company financials, sources of financing, method of payment, deal values, and advisors for various parties, where disclosed.
Our reports have been used by over 10K customers, including:
Tissue Engineering Market Research Report by Material (Biomimetic Material, Composite Material, Nano-Composite Material, and Nano-Fibrous Material), by Application (Cancer, Cardiology, Cord Blood & Cell Banking, Dental, and GI & Gynaecology) - Global Forecast to 2025 - Cumulative Impact of COVID-19 Market Statistics: The...
Biosimilar Monoclonal Antibodies Market Research Report by Drug Class (Abciximab, Adalimumab, Bevacizumab, Infliximab, and Rituximab), by Application (Diagnostic, Protein Purification, and Therapeutic) - Global Forecast to 2025 - Cumulative Impact of COVID-19 Market Statistics: The report provides market sizing and...
Cell Analysis Market Research Report by Product (Cell Counters, Cell Microarrays, Flow Cytometry Products, High-Content Screening Systems, and Microscopes), by Process (Cell Counting & Quality Control, Cell Identification, Cell Interaction, Cell Proliferation, and Cell Signaling Pathway/Signal Transduction), by End User - Global Forecast...
Cell Therapy Technologies Market Research Report by Product (Consumables, Equipment, and Systems & Software), by Process (Cell Preservation, Distribution, and Handling, Cell Processing, and Process Monitoring and Quality Control), by Cell Type, by End User - Global Forecast to 2025 - Cumulative Impact of COVID-19 Market...
2021 US Cancer Diagnostics Market Assessment--Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts for Major Tumor Markers, Latest Technologies and Instrumentation Pipeline, Emerging Opportunities for Suppliers This new report is a study of the major business opportunities emerging in the...
Cell Line Development Market Research Report by Type (Continuous Cell Lines, Hybridomas, Primary Cell Lines, and Recombinant Cell Lines), by Source (Amphibian, Insect, and Mammalian), by Product, by Application - Global Forecast to 2025 - Cumulative Impact of COVID-19 Market Statistics: The report provides market...
200 pages •
By The Business Research Company
• Dec 2020
Major players in the cancer monoclonal antibodies market are Amgen, Bristol Myers Squibb Company, Eli Lilly and Company, F. Hoffmann-La Roche Ltd, Genmab AS, GlaxoSmithKline, Johnson & Johnson, Novartis AG, Merck & Co., and Spectrum Pharmaceuticals. The global cancer monoclonal antibodies market is expected to decline from $48.36 billion...
The cell culturemarket is projected to reach USD 33.1 billion by 2025 from USD 19.0 billion in 2020, at a CAGR of 11.8% during the forecast period. The growth of this market is majorly driven by the growing awareness about the benefits of cell culture-based vaccines, increasing demand for monoclonal antibodies (mAbs), funding for cell-based...
The Global Proteomics Partnering Terms and Agreements 2010 to 2020 report provides an understanding and access to the Proteomics partnering deals and agreements entered into by the worlds leading healthcare companies. Trends in Proteomics partnering deals Disclosed headlines, upfronts, milestones and royalties by...
“BENRALIZUMAB- Emerging Insight and Market Forecast – 2030” the report provides comprehensive insights about an investigational product for Chronic Spontaneous Urticaria in 7 Major Markets. A detailed picture of the BENRALIZUMAB in Seven Major Markets, i.e., United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan,...
By continuing to use this site you consent to the use of cookies on your device as described in our Cookie Policy unless you have disabled them.
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.